{"id":"NCT00133705","sponsor":"University of Rochester","briefTitle":"Trial of Mifepristone for Fibroids","officialTitle":"Randomized Control Trial Of Mifepristone for Fibroids","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-07","primaryCompletion":"2010-06","completion":"2010-06","firstPosted":"2005-08-23","resultsPosted":"2012-11-30","lastUpdate":"2023-09-25"},"enrollment":70,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Leiomyoma"],"interventions":[{"type":"DRUG","name":"Mifepristone","otherNames":["RU486"]},{"type":"DRUG","name":"Inert Capsule","otherNames":[]}],"arms":[{"label":"Mifepristone","type":"EXPERIMENTAL"},{"label":"Inert capsule","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to determine if low-dose mifepristone benefits women with symptomatic fibroids.","primaryOutcome":{"measure":"Uterine Volume","timeFrame":"6 months","effectByArm":[{"arm":"Treatment Group","deltaMin":719,"sd":663},{"arm":"Placebo Group","deltaMin":449,"sd":236}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":15},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["15922980","12576246","17138770"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":[]}}